Vericel Corp
For the period ended Jun 30, 2024. Filed Aug 1, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 1, 2024
VCEL$54.62+5.5%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Exhibit Index
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Exhibit Number | Description of Exhibits | Form | File Number | Exhibit | Filing Date |
| 3.1 | Restated Articles of Incorporation of the Company. | 8-K | 000-22025 | 4.1 | December 17, 2009 |
| 3.2 | Certificate of Amendment to Restated Articles of Incorporation of the Company dated February 9, 2010. | S-1 | 333-160044 | 3.2 | March 31, 2010 |
| 3.3 | Certificate of Amendment to Restated Articles of Incorporation of the Company dated March 22, 2011. | 8-K | 000-22025 | 3.1 | March 25, 2011 |
| 3.4 | Certificate of Amendment to the Restated Articles of Incorporation of the Company, dated November 21, 2014. | 8-K | 001-35280 | 3.1 | November 24, 2014 |
| 3.5 | Amended and restated bylaws. | 8-K | 000-22025 | 3.1 | November 12, 2010 |
| 4.1 | Description of Capital Stock. | 10-K | 001-35280 | 4.5 | February 25, 2020 |
| 31.1* | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 31.2* | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.1* | Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 10.1†* | Fourth Amendment to the Dispensing Agreement between AllCare Plus Pharmacy, Inc. and the Company, dated June 1, 2024. | ||||
| 10.2* | Tenth Amendment to the Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated July 1, 2024. | ||||
| 101.INS* | Inline XBRL Instance Document | ||||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document | ||||
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
| 104* | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) | ||||
Management contract or compensatory plan or arrangement covering executive officers or directors of Vericel.
† Certain immaterial and confidential portions of this exhibit have been omitted in accordance with Item 601 (a)(5) of Regulation S-K.
- Filed herewith.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.